As per today's interim results, reveune up by 6%, EBITDA is up by 29%. EBITDA margin is 27%. Look the half-year financial statements, "product and technologies expenses(another name for "R & D") has been down by 44%. That is exactly what I expect: as long as IRI revenue goes up, R & D comes down, its EBITDA margin goes up substantially.
As per today's interim results, reveune up by 6%, EBITDA is up...
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
-0.010(1.30%) |
Mkt cap ! $132.7M | |||
| Open | High | Low | Value | Volume |
| 77.5¢ | 79.0¢ | 76.0¢ | $132.1K | 169.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22374 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 1020 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IRI (ASX) Chart |